BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38007380)

  • 1. Spontaneous tumor lysis syndrome in a patient with chronic myeloid leukemia treated successfully with allopurinol.
    Gartenberg A; Winkel M; Leonard N
    Am J Emerg Med; 2024 Apr; 78():242.e1-242.e3. PubMed ID: 38007380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and treatment of tumor lysis syndrome in patients with acute leukemia.
    Razis E; Arlin ZA; Ahmed T; Feldman EJ; Puccio C; Cook P; Chun HG; Helson L; Mittelman A
    Acta Haematol; 1994; 91(4):171-4. PubMed ID: 7976113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydroxyurea and splenic irradiation-induced tumour lysis syndrome: a case report and review of the literature.
    Chen SW; Hwang WS; Tsao CJ; Liu HS; Huang GC
    J Clin Pharm Ther; 2005 Dec; 30(6):623-5. PubMed ID: 16336296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chronic-phase chronic myeloid leukemia with intracranial hemorrhage complicated with tumor lysis syndrome].
    Oyama C; Arakawa Y; Ikeda Y; Aoki T; Kubota Y; Isobe K; Mori M; Kurihara J; Koh K
    Rinsho Ketsueki; 2021; 62(5):346-351. PubMed ID: 34108312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
    Baeksgaard L; Sørensen JB
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor lysis syndrome: a systematic review of case series and case reports.
    Firwana BM; Hasan R; Hasan N; Alahdab F; Alnahhas I; Hasan S; Varon J
    Postgrad Med; 2012 Mar; 124(2):92-101. PubMed ID: 22437219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the rasburicase era.
    Toda Y; Ashizawa M; Murahashi R; Nakashima H; Ikeda T; Kawaguchi SI; Nagayama T; Umino K; Minakata D; Morita K; Yamamoto C; Hatano K; Sato K; Fujiwara SI; Ohmine K; Kanda Y
    Int J Hematol; 2024 Jun; 119(6):660-666. PubMed ID: 38575822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Lysis Syndrome.
    Barbar T; Jaffer Sathick I
    Adv Chronic Kidney Dis; 2021 Sep; 28(5):438-446.e1. PubMed ID: 35190110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of single-dose rasburicase in an obese female.
    Arnold TM; Reuter JP; Delman BS; Shanholtz CB
    Ann Pharmacother; 2004 Sep; 38(9):1428-31. PubMed ID: 15292497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency care: the tumor lysis syndrome.
    Turtureanu-Hanganu E
    Rev Med Chir Soc Med Nat Iasi; 2002; 106(4):705-11. PubMed ID: 14974215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor lysis syndrome: risk factors, diagnosis, and management.
    Burns RA; Topoz I; Reynolds SL
    Pediatr Emerg Care; 2014 Aug; 30(8):571-6; quiz 577-9. PubMed ID: 25098804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of tumour lysis syndrome during first-line palliative chemotherapy for high-volume colorectal cancer.
    Gouveia HS; Lopes SO; Faria AL
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29545434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous tumour lysis syndrome secondary to the transformation of chronic myelomonocytic leukaemia into acute myeloid leukaemia.
    Langridge A; Musgrave K; Upadhye Y
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26961554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of plasma uric acid in adults at risk for tumor Lysis syndrome: efficacy and safety of rasburicase alone and rasburicase followed by allopurinol compared with allopurinol alone--results of a multicenter phase III study.
    Cortes J; Moore JO; Maziarz RT; Wetzler M; Craig M; Matous J; Luger S; Dey BR; Schiller GJ; Pham D; Abboud CN; Krishnamurthy M; Brown A; Laadem A; Seiter K
    J Clin Oncol; 2010 Sep; 28(27):4207-13. PubMed ID: 20713865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous tumor lysis syndrome in acute myeloid leukemia: two cases and a review of the literature.
    Riccio B; Mato A; Olson EM; Berns JS; Luger S
    Cancer Biol Ther; 2006 Dec; 5(12):1614-7. PubMed ID: 17204864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor Lysis Syndrome in the Chronic Phase of Chronic Myeloid Leukemia Following COVID-19 Infection: A Case Report.
    Waseem Hajjar AH; Abbarh S; Al-Mashdali A; Alshurafa A; Abu-Tineh M; Qasim H; Ahmed K; Yassin MA
    Cureus; 2022 Apr; 14(4):e24386. PubMed ID: 35619871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor lysis syndrome soon after treatment with hydroxyurea followed by nilotinib in two patients with chronic-phase chronic myelogenous leukemia.
    Hua J; Iwaki Y; Inoue M; Hagihara M
    Int J Hematol; 2013 Aug; 98(2):243-6. PubMed ID: 23649869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
    Găman AM; Dobrea C; Rotaru I
    Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Case of Spontaneous Tumor Lysis Syndrome in Idiopathic Primary Myelofibrosis.
    Na YS; Park SG
    Am J Case Rep; 2019 Feb; 20():146-150. PubMed ID: 30712053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib-induced tumor lysis syndrome: report of a case and review of the literature.
    Chang H; Shih LY
    Chang Gung Med J; 2008; 31(5):510-4. PubMed ID: 19097599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.